Publication:
Evaluation of targeted delivery of specific antisense oligonucleotides via engineered exosomes to combat Covid-19 disease using human airway epithelial cultures

dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBayram, Hasan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:57:23Z
dc.date.issued2024
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuTÜBİTAK
dc.description.sponsorshipThis abstract is funded by: scientific and technological research council of turkey (TÜBİTAK)
dc.identifier.eissn1535-4970
dc.identifier.grantnoscientific and technological research council of turkey (TÜBİTAK)
dc.identifier.issn1073-449X
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27219
dc.identifier.volume209
dc.identifier.wos1277613400083
dc.keywordsEngineered exosomes
dc.keywordsCOVID-19
dc.keywordsHuman airway epithelial cultures
dc.keywordsTherapeutic strategy
dc.keywordsGene silencing
dc.keywordsViral infection
dc.keywordsExosome engineering
dc.language.isoeng
dc.publisherAmerican Thoracic Society
dc.relation.ispartofAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
dc.subjectCritical care medicine
dc.subjectRespiratory system
dc.titleEvaluation of targeted delivery of specific antisense oligonucleotides via engineered exosomes to combat Covid-19 disease using human airway epithelial cultures
dc.typeOther
dc.type.otherMeeting abstract
dspace.entity.typePublication
local.contributor.kuauthorBayram, Hasan
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files